Metraipolis › archive › dc_f81f2b5aba03

Integrating CAR-T therapy with PD-1/PD-L1 blockade: Mechanisms, synergy, and optimized strategies in NSCLC — Europe PMC PMID:41675056

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41675056
DOI
10.1016/j.isci.2025.114607
License (as archived)
solo-consultazione
Archived
2026-11-06T19:36:59.231Z
SHA-256 of the archived text
5ddcf3a30454a013037209a39d8ceb67b58dbcf37612e17ebf869729b6cba17f
Stable URL of this page
https://metraipolis.com/documento/dc_f81f2b5aba03

How to cite

Integrating CAR-T therapy with PD-1/PD-L1 blockade: Mechanisms, synergy, and optimized strategies in NSCLC — Europe PMC PMID:41675056 — Europe PMC (en), https://europepmc.org/article/MED/41675056 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f81f2b5aba03 (Metraipolis archive dc_f81f2b5aba03, sha256 5ddcf3a30454a013037209a39d8ceb67b58dbcf37612e17ebf869729b6cba17f)
BibTeX
@misc{dcf81f2b5aba03,
  title = {Integrating CAR-T therapy with PD-1/PD-L1 blockade: Mechanisms, synergy, and optimized strategies in NSCLC — Europe PMC PMID:41675056},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41675056},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f81f2b5aba03; sha256 5ddcf3a30454a013037209a39d8ceb67b58dbcf37612e17ebf869729b6cba17f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41675056. Agents can read the archived copy with the MCP tool read_document.